CME Group Inc. (NASDAQ:CME) Insider Sells $1,019,880.00 in Stock

CME Group Inc. (NASDAQ:CME) insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares in the company, valued at approximately $6,131,291.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

CME Group Price Performance

CME opened at $223.61 on Friday. The firm has a 50-day moving average price of $220.69 and a 200-day moving average price of $209.46. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $80.52 billion, a price-to-earnings ratio of 23.51, a PEG ratio of 5.72 and a beta of 0.55.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm posted $2.25 EPS. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. Equities analysts expect that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were issued a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. CME Group’s payout ratio is currently 48.37%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Bank of America lifted their price target on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Piper Sandler boosted their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Oppenheimer increased their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. JPMorgan Chase & Co. boosted their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Finally, Morgan Stanley upped their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and an average target price of $222.73.

Institutional Investors Weigh In On CME Group

Several large investors have recently added to or reduced their stakes in CME. Salomon & Ludwin LLC purchased a new stake in shares of CME Group in the 1st quarter valued at about $28,000. Y.D. More Investments Ltd bought a new stake in CME Group during the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. lifted its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC grew its stake in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after buying an additional 74 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.